Pro-Pharmaceuticals, Inc. Issues Corporate Update; Outlines Achievements And Key Clinical Milestones

NEWTON, Mass.--(BUSINESS WIRE)--Dec. 9, 2005--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate compounds that enable the targeted delivery of drugs, is issuing a corporate update in the following letter that is being mailed to its stockholders.

MORE ON THIS TOPIC